Biggest changeThe Company’s development team includes optical engineers, mathematicians, physicists, and software developers. 29 Results of Operations Our results of operations for the years ended December 31, 2024 and 2023 is as follows (in thousands, except percentages): Year Ended December 31, 2024 2023 % Change Revenue: Total revenue $ 373 $ 358 4 % Gross profit 112 162 (31 )% Gross profit margin 30 % 45 % Operating expenses: Research and development 11,318 8,891 27 % Sales and marketing 1,818 1,806 1 % General and administrative 12,913 15,708 (18 )% Total operating expenses 26,049 26,405 (1 )% Loss from operations (25,937 ) (26,243 ) (1 )% Non-operating income and (expense): Interest and other income 423 295 43 % Interest expense, net (2,496 ) (1,602 ) 56 % Change in fair value of warrant liabilities (40,532 ) 528 NM Total non-operating income (expense) (42,605 ) (779 ) NM Net loss $ (68,542 ) $ (27,022 ) 154 % Revenues The Company’s revenues during the years ended December 31, 2024 and 2023 consisted of (in thousands): Year Ended December 31, 2024 2023 % Change Services $ 346 $ 353 (2 )% Products 27 5 440 % Total $ 373 $ 358 4 % Revenues for the year ended December 31, 2024 were $373 thousand compared to $358 thousand for the year ended December 31, 2023, an increase of $15 thousand, or 4%.
Biggest changeTrade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations. 37 Results of Operations Our results of operations for the years ended December 31, 2025 and 2024 is as follows (in thousands, except percentages): Year Ended December 31, 2025 2024 % Change Revenue: Total revenue $ 682 $ 373 83 % Gross profit 67 112 (40 )% Gross profit margin 10 % 30 % Operating expenses: Research and development 20,473 11,318 81 % Sales and marketing 3,431 1,818 89 % General and administrative 27,240 12,913 111 % Total operating expenses 51,144 26,049 96 % Loss from operations (51,077 ) (25,937 ) 97 % Non-operating income and (expense): Interest and other income, net 20,718 423 4,798 % Interest expense (65 ) (2,496 ) (97 )% Change in fair value of derivative liability 11,750 (40,532 ) 129 % Total non-operating income (expense), net 32,403 (42,605 ) (176 )% Net loss $ (18,674 ) $ (68,542 ) (73 )% Revenues The Company’s revenues during the years ended December 31, 2025 and 2024 consisted of (in thousands): Year Ended December 31, 2025 2024 % Change Services $ 368 $ 346 6 % Products 314 27 1,063 % Total $ 682 $ 373 83 % Revenues for the year ended December 31, 2025 were $682 thousand compared to $373 thousand for the year ended December 31, 2024, an increase of $309 thousand, or 83%.
In particular, uncertain and unfavorable conditions in the United States and global macroeconomic environment, including inflationary pressures, rising interest rates, bank failures, and financial and credit market fluctuations, could reduce our ability to access capital on favorable terms, or at all.
In particular, uncertain and unfavorable conditions in the United States and global macroeconomic environment, including inflationary pressures, interest rates, bank failures, and financial and credit market fluctuations, could reduce our ability to access capital on favorable terms, or at all.
As much revenues will be derived from the sales of our products and services, our business operations may be adversely affected by the products and services offered by our competitors and any prolonged recession periods.
As revenues will be derived from the sales of our products and services, our business operations may be adversely affected by the products and services offered by our competitors and any prolonged recession periods.
The year-over-year change was driven by changes in the number of, size of and level of effort performed on active customer proof of concept and research and development services and customer hardware contracts. In 2024, the Company continued to execute its business strategy to provide quantum-ready solutions for solving real-world problems.
The year-over-year change was driven by changes in the number of, size of and level of effort performed on active customer proof of concept and research and development services and customer hardware contracts. In 2025, the Company continued to execute its business strategy to provide quantum-ready solutions for solving real-world problems.
If our assumptions change and we determine we will be able to realize these NOLs, the tax benefits relating to any reversal of the valuation allowance on deferred tax assets as of December 31, 2024, will be accounted for as a reduction of income tax expense.
If our assumptions change and we determine we will be able to realize these NOLs, the tax benefits relating to any reversal of the valuation allowance on deferred tax assets as of December 31, 2025, will be accounted for as a reduction of income tax expense.
Non-operating Income (Expense) The following table summarizes our non-operating income (expense) for the years ended December 31, 2024 and 2023 (in thousands, except percentages).
Non-operating Income (Expense) The following table summarizes our non-operating income (expense) for the years ended December 31, 2025 and 2024 (in thousands, except percentages).
Accordingly, as of December 31, 2024 and 2023, we had only issued 6,325,503 of the QPhoton Warrants.
Accordingly, as of December 31, 2025 and 2024, we had only issued 6,325,503 of the QPhoton Warrants.
Cost of revenues for each of the years ended December 31, 2024 and 2023 consists primarily of salary expense.
Cost of revenues for each of the years ended December 31, 2025 and 2024 consists primarily of salary expense.
We will require a significant amount of cash for continued investment in our Foundry Services offering, including but not limited to our AZ Chips Facility and any future-identified space for expansion, as well as ongoing research and development for our non-linear quantum optical products and photonics chips.
We will require a significant amount of cash for continued investment in our Foundry Services offering, including but not limited to future-identified space for expansion of our AZ Chips Facility, as well as the construction or acquisition of a high-volume chip manufacturing facility, as well as ongoing research and development for our non-linear quantum optical products and photonics chips.
See Note 7, Financial Liabilities , in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information. Liquidity and Capital Resources We have incurred net losses and experienced negative cash flows from operations since inception.
See Note 12, Capital Stock , in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information on the QPhoton Warrants. 40 Liquidity and Capital Resources We have incurred net losses and experienced negative cash flows from operations since inception.
A third alleged shareholder, BV Advisory, rejected the Merger Consideration and commenced litigation in Delaware Chancery Court (see Note 8, Contingencies – Legal Proceedings , in this Form 10-K for additional information and Item 3, Legal Proceedings , in this Form 10-K for a full discussion), and to date that litigation has not been resolved.
A third alleged shareholder, BV Advisory, rejected the Merger Consideration and commenced litigation in Delaware Chancery Court (see Note 10, Contingencies - Legal Proceedings , in this Form 10-K for additional information and Item 3, Legal Proceedings , in this Form 10-K for a full discussion). That litigation was resolved in 2025.
The loss on change in value of warrant liability is entirely comprised of mark-to-market adjustments for the QPhoton Warrants, as defined below in the accompanying notes to our consolidated financial statements appearing elsewhere in this report, which had no carrying value as of December 31, 2023.
See Note 12, Capital Stock , in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information on the QPhoton Warrants The loss on change in value of derivative liability is entirely comprised of mark-to-market adjustments for the QPhoton Warrants, as defined below in the accompanying notes to our consolidated financial statements appearing elsewhere in this report, which had no carrying value as of December 31, 2023.
Fair Value of Warrant Liabilities and Derivatives Determining the fair market value of the QPhoton Warrants, which were included in the merger consideration paid to the stockholders of QPhoton (the “QPhoton Merger Consideration”), is a critical accounting estimate.
Fair Value of Derivative Liability Determining the fair market value of the QPhoton Warrants, which were included in the merger consideration paid to the stockholders of QPhoton (the “QPhoton Merger Consideration”), is a critical accounting estimate.
In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating results. As of December 31, 2024, we had federal and state net operating loss (“NOL”) carryforwards of approximately $89.4 million, or $19.6 million on a tax-effected basis.
In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating results. As of December 31, 2025, we had federal and state net operating loss (“NOL”) carryforwards of approximately $158.1 million, or $27.1 million on a tax-effected basis.
The Company is developing quantum and ancillary non-quantum products for high-performance computing applications based on proprietary photonics technology. QCi’s products are designed to operate at room temperature and low power at an affordable cost in the areas of high-performance computing, sensing and imaging, and quantum cybersecurity.
Overview QCi is a development stage company with limited operations and revenue. The Company is developing quantum and ancillary non-quantum products for high-performance computing applications based on proprietary photonics technology. QCi’s products are designed to operate at room temperature and low power at an affordable cost in the areas of high-performance computing, sensing, and quantum cybersecurity.
Year Ended December 31, % 2024 2023 Change General and administrative $ 12,913 $ 15,708 (18 )% General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.
Year Ended December 31, % 2025 2024 Change General and administrative $ 27,240 $ 12,913 111 % General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.
In determining whether a loss should be accrued we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our consolidated financial statements. 35 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. Not applicable.
In determining whether a loss should be accrued we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our consolidated financial statements.
Cash Flows The following table summarizes our cash flow for the years ended December 31, 2024 and 2023 (in thousands): Year Ended December 31, 2024 2023 Net cash used in operating activities $ (16,213 ) $ (18,315 ) Net cash used in investing activities (6,036 ) (2,612 ) Net cash provided by financing activities 99,135 17,678 Net increase (decrease) in cash and cash equivalents $ 76,886 $ (3,249 ) Net cash used in operating activities for the years ended December 31, 2024 and 2023 was $16.2 million and $18.3 million, respectively, in each case primarily as a result of our net loss in each period offset by noncash adjustments for stock-based compensation, mark-to-market valuation adjustments on financial liabilities, and depreciation and amortization.
Cash Flows The following table summarizes our cash flow for the years ended December 31, 2025 and 2024 (in thousands): Year Ended December 31, 2025 2024 Net cash used in operating activities $ (30,294 ) $ (16,213 ) Net cash used in investing activities (788,327 ) (6,036 ) Net cash provided by financing activities 1,477,556 99,135 Net increase in cash and cash equivalents $ 658,935 $ 76,886 41 Cash Flows from Operating Activities Net cash used in operating activities for the years ended December 31, 2025 and 2024 was $30.3 million and $16.2 million, respectively, in each case primarily as a result of our net loss in each period offset by noncash adjustments for stock-based compensation, mark-to-market valuation adjustments on derivative liabilities, and depreciation and amortization.
Our lack of a scaled and distributed base of revenue generation by product and sales channel can result in significant differences in gross margin between reporting periods.
Our lack of a scaled and distributed base of revenue generation by product and sales channel can result in significant differences in gross margin between reporting periods. We anticipate product gross margins will improve as we build additional units of each product.
Year Ended December 31, % 2024 2023 Change Research and development $ 11,318 $ 8,891 27 % Research and development expenses consist primarily of compensation for employees that primarily engage in research and development efforts and fees for the development of hardware products and supporting software.
Year Ended December 31, % 2025 2024 Change Research and development $ 20,473 $ 11,318 81 % 39 Research and development expenses consist primarily of labor expenses for employees that primarily engage in research and development efforts and non-labor expenses for the development of hardware products and supporting software.
In determining the fair market value of the QPhoton Warrants, the Company determines which underlying options and warrants are in-the-money or out-of-the-money at period end by comparing to the bid price of the Company’s common stock, then accounts for changes period-over-period by realizing a mark-to-market gain or loss for the period.
In determining the fair market value of the QPhoton Warrants, the Company determines which underlying options and warrants are in-the-money or out-of-the-money at period end by comparing to the bid price of the Company’s common stock, then accounts for changes period-over-period by realizing a mark-to-market gain or loss for the period. 42 An additional critical accounting estimates involves determining the fair value of the conversion features inherent in the Streeterville Convertible Note (the “Streeterville Derivative Liability”), which involves inherent uncertainties and the application of management judgement.
Cost of Revenues Cost of revenues, which consists of direct labor expenses, primarily salary costs for engineering and solutions staff delivering services, and other direct component costs for custom hardware on research and development contracts, was $261 thousand for the year ended December 31, 2024, compared to $196 thousand for the prior year, an increase of $65 thousand, or 33%.
The Company also started to recognize revenue for cloud-based access to the Dirac-3 quantum optimization system during 2025. 38 Cost of Revenues Cost of revenue, which consists of direct labor expenses, primarily salary costs for engineering and solutions staff delivering services, and other direct component costs for custom hardware on research and development contracts, was $615 thousand for the year ended December 31, 2025, compared to $261 thousand for the prior year, an increase of $354 thousand, or 136%.
Revenue was derived from sales of hardware products and professional services in 2024 and 2023, in each case provided to multiple commercial and government customers under multi-month contracts.
Revenue was derived from sales of hardware products and professional services in 2025 and 2024, in each case provided to multiple commercial and government customers under multi-month contracts. Product revenue increased substantially compared to 2024 due to successful sales of vibrometer and quantum networking devices which were delivered during 2025.
Because of the complexity of some of these uncertainties, the ultimate resolution may result in a tax payment that is materially different from our current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is made available.
Because of the complexity of some of these uncertainties, the ultimate resolution may result in a tax payment that is materially different from our current estimate of the unrecognized tax benefit liabilities.
Net cash used in investing activities for the years ended December 31, 2024 and 2023 was $6.0 million and $2.6 million, respectively, and was attributable to our purchase of TFLN Optical Chips manufacturing equipment for our AZ Chips Facility, as well as computer hardware and laboratory equipment.
Cash Flows from Investing Activities Net cash used in investing activities for the years ended December 31, 2025 and 2024 was $788.3 million and $6.0 million, respectively, and was attributable to our purchase of computer hardware, laboratory equipment and TFLN Chips manufacturing equipment, as well as the purchase of $1,197.9 million in available-for-sale-debt securities offset by $376.3 million in proceeds from sales of available-for-sale-debt securities.
We believe that none of the unrecognized tax benefits may be recognized by the end of 2024. Legal and Other Contingencies The outcomes of legal proceedings and claims brought against us are subject to significant uncertainty.
These differences will be reflected as increases or decreases to income tax expense in the period in which new information is made available. 43 We believe that none of the unrecognized tax benefits may be recognized by the end of 2026. Legal and Other Contingencies The outcomes of legal proceedings and claims brought against us are subject to significant uncertainty.
Operating Expenses Operating expenses of approximately $26.0 million in 2024 decreased as compared to approximately $26.4 million in 2023 primarily as a result of a decrease in general and administrative expenses, partially offset by an increase in research and development expenses, as set forth in the below tables (in thousands, except percentages).
Operating Expenses Operating expenses of approximately $51.1 million during the year ended December 31, 2025 increased as compared to approximately $26.0 million in 2024 primarily as a result of higher research and development expenses, sales and marketing expenses and general and administrative expenses, as set forth in the below tables (in thousands, except percentages).
The Streeterville Derivative Liability will be mark-to-market adjusted on a quarterly basis and accreted as interest expense while the Streeterville Convertible Note is outstanding. 34 Fair Market Value and Useful Life of Intangible Assets Determining the fair market value and useful life of the intangible assets acquired by the Company through the QPhoton Merger is another critical accounting estimate.
Fair Market Value and Useful Life of Intangible Assets Determining the fair market value and useful life of the intangible assets acquired by the Company through the QPhoton Merger is another critical accounting estimate.
See “Forward-Looking Statements.” You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K, Overview QCi is a development stage company with limited operations and revenue.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included in this Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties.
Research and development expenses in 2024 increased $2.4 million or 27% compared with 2023 primarily due to higher employee-related expenses, primarily as a result of higher stock-based compensation and bonus expenses to incentivize and retain key technologists, as well as higher depreciation for long-lived laboratory equipment, offset partially by lower professional and hosting services.
Research and development expenses during the year ended December 31, 2025 increased $9.2 million or 81% compared with 2024 primarily due to higher headcount and related payroll costs, higher recurring lab equipment and consumables costs, and higher depreciation for long-lived laboratory equipment, partially offset by lower hosting services expenses and lower stock based compensation expense.
Year Ended December 31, % 2024 2023 Change Sales and marketing $ 1,818 $ 1,806 1 % Selling and marketing expenses consist primarily of employee compensation as well as customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs. 31 Net selling and marketing expenses in 2024 were largely unchanged as compared with 2023, with increases primarily due to higher stock-based compensation, offset by lower outsourced professional services costs, related marketing program costs, and lower trade show and travel-related costs in 2024.
Year Ended December 31, % 2025 2024 Change Sales and marketing $ 3,431 $ 1,818 89 % Sales and marketing expenses consist primarily of employee compensation as well as customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs.
We expect to incur additional losses and higher operating expenses for the foreseeable future as we continue to invest in research and development and go-to-market programs. As of December 31, 2024, the Company had cash and cash equivalents of $78.9 million.
During the year ended December 31, 2025, the Company raised net proceeds of $1,475.1 million through the private placement of equity. The Company has no lines of credit or short-term debt obligations outstanding. We expect to incur additional losses and higher operating expenses for the foreseeable future as we continue to invest in research and development and go-to-market programs.
We believe, however, that the Company’s existing cash and cash equivalents, together with any cash generated from operations and the proceeds from any additional equity or debt issuances will be sufficient to meet the Company’s liquidity needs for at least the next 12 months. 32 The following table summarizes total current assets, liabilities and working capital at December 31, 2024, compared to December 31, 2023 (in thousands): December 31, 2024 December 31, 2023 Increase/ (Decrease) Current assets $ 79,151 $ 2,656 $ 76,495 Current liabilities $ 4,559 $ 4,812 $ (253 ) Working capital (deficit) $ 74,592 $ (2,156 ) $ 76,748 At December 31, 2024, we had working capital of $74.6 million as compared to working capital deficit of $2.2 million at December 31, 2023, an increase of $76.8 million.
We believe, however, that the Company’s existing cash and cash equivalents, together with any cash generated from operations and the proceeds from any additional equity or debt issuances will be sufficient to meet the Company’s liquidity needs for at least the next 12 months.
The following discussion and analysis of the results of operations and financial condition for the years ended December 31, 2024 and 2023 should be read in conjunction with our consolidated financial statements and the notes to those consolidated financial statements that are included elsewhere in this Annual Report.
Discussions of 2023 items and year-to-year comparisons between 2024 and 2023 that are not included in this Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 20, 2025.
The increase in 2024 is primarily due to the purchase of additional equipment in connection with establishing the AZ Chip Facility. 33 Net cash provided by financing activities for the years ended December 31, 2024 and 2023 was $99.1 million and $17.7 million, respectively.
Cash Flows from Financing Activities Net cash provided by financing activities for the years ended December 31, 2025 and 2024 was $1,477.6 million and $99.1 million, respectively. Cash flows provided by financing activities during year ended December 31, 2025 were primarily attributable to net proceeds from our stock issuances.
The increase for 2024 was predominantly driven by the increases in direct labor expenses and other direct costs required to perform on the contracts during 2024 compared to the prior year. 30 Gross Margin Gross margin for the year ended December 31, 2024 was $112 thousand compared to $162 thousand for the prior year, a decrease of $50 thousand, or 31%.
The increase for 2025 was primarily due to the increases in direct labor expenses on R&D services contracts and custom hardware contracts, an increase in production overhead, and increased other direct costs (primarily parts and materials) required to perform on the contracts during the 2025 compared to the prior year.
Year Ended December 31 % 2024 2023 Change Interest and other income $ 423 $ 295 43 % Interest expense, net (2,496 ) (1,602 ) 56 % Change in value of derivative and warrant liabilities (40,532 ) 528 NM Other income (expense) $ (42,605 ) $ (779 ) NM Non-operating expense increased to $42.6 million for 2024 compared to $779 thousand for 2023, primarily as the result of a $40.5 million decrease in the change in fair value of the derivative liability for the QPhoton Warrants, as defined below, during 2024 compared to a $528 thousand increase in 2023.
Interest expense during the year ended December 31, 2025 is related to late payroll tax filings. Change in fair value of derivative and warrant liability during the year ended December 31, 2025 increased $52,282 or 129% compared with 2024 as a result of the change in the fair value of the QPhoton Warrant Liability (as defined below).
Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors.
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors including, but not limited to, those discussed under Item 1A, “Risk Factors.” The following analysis generally discusses 2025 and 2024 items and year-to-year comparisons between 2025 and 2024.